Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Kuros Biosciences AG (SW: KURN)

 
KURN Technical Analysis
5
As on 22nd Nov 2024 KURN STOCK Price closed @ 24.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.77 & Strong Buy for SHORT-TERM with Stoploss of 1.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

KURNSTOCK Price

Open 23.00 Change Price %
High 24.30 1 Day 1.90 8.48
Low 23.00 1 Week -4.90 -16.78
Close 24.30 1 Month 6.18 34.11
Volume 280419 1 Year 22.96 1713.43
52 Week High 31.25 | 52 Week Low 1.25
 
SW Switzerland Most Active Stocks
CSGN 0.82 0.00%
CSGN 0.82 0.00%
NESN 76.00 0.05%
NESN 76.00 0.05%
UBSG 28.30 0.57%
UBSG 28.30 0.57%
NOVN 93.68 2.32%
NOVN 93.68 2.32%
ABBN 50.16 1.17%
ABBN 50.16 1.17%
 
SW Switzerland Top Gainers Stocks
CADN 0.03 50.00%
PRFN 0.03 50.00%
PRFN 0.03 50.00%
HLEE 7.20 35.85%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
MBTN 0.38 15.15%
CASN 1.90 8.57%
 
SW Switzerland Top Losers Stocks
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
AAM 28.20 -8.44%
AAM 28.20 -8.44%
 
 
KURN
Daily Charts		 KURN
Intraday Charts		 Whats New @
Bazaartrend		 KURN
Free Analysis
 
KURN Important Levels Intraday
RESISTANCE26.81
RESISTANCE26.00
RESISTANCE25.51
RESISTANCE25.01
SUPPORT23.59
SUPPORT23.09
SUPPORT22.60
SUPPORT21.79
 
KURN Forecast November 2024
Share
4th UP Forecast27.19
3rd UP Forecast26.26
2nd UP Forecast25.69
1st UP Forecast25.12
1st DOWN Forecast23.48
2nd DOWN Forecast22.91
3rd DOWN Forecast22.34
4th DOWN Forecast21.41
 
KURN Weekly Forecast
4th UP Forecast24.69
3rd UP Forecast24.56
2nd UP Forecast24.49
1st UP Forecast24.41
1st DOWN Forecast24.19
2nd DOWN Forecast24.11
3rd DOWN Forecast24.04
4th DOWN Forecast23.91
 
KURN Forecast2024
4th UP Forecast83.56
3rd UP Forecast64.55
2nd UP Forecast52.81
1st UP Forecast41.06
1st DOWN Forecast7.54
2nd DOWN Forecast-4.21
3rd DOWN Forecast-15.95
4th DOWN Forecast-34.96
 
 
KURN Other Details
Segment EQ
Market Capital 72147024.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
KURN Address
KURN
 
KURN Latest News
 
Your Comments and Response on Kuros Biosciences AG
 
KURN Business Profile
Kuros Biosciences AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases in the United States, the United Kingdom, and internationally. Its sealants pipeline products include Neuroseal EU and US for the treatment of dural sealant cranial. The company's orthobiologics pipeline products include MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products comprise KUR-111, which has completed Phase II clinical trial for the treatment of tibial plateau fractures; and KUR-113, which completed Phase II clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase I trial for the treatment of spinal interbody fusion. The company has collaboration with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. Kuros Biosciences AG is headquartered in Schlieren, Switzerland. Address: Wagistrasse 25, Schlieren, Switzerland, 8952
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service